← Leaderboards
Benjamin Jacob Doranz
Integral Molecular
$24,054,261
Attributed
$24,054,261
Total exposure
26
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,054,261 · 26
By mechanism
R44$11,328,091 · 7
N01$5,167,725 · 1
R43$4,366,833 · 15
SB1$1,846,470 · 1
R01$845,142 · 1
U01$500,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyCellsAbbreviationsPharmaceutical PreparationsAntibodiesMembraneProteinsMembrane ProteinsSpecificityTimelineMolecularMonoclonal AntibodiesStructureNovel StrategiesEpitopesProteomeLibrariesHuman DiseaseNew TechnologyLigandsIndustryBindingMolecular ConformationProduction
Grant awards (53)
Specificity Screening Drug Development Tool for Biotherapeutic Safety$929,016
SB1 · FY2025 · GM · contact PI
Development of Safe and Rapid Reporter Viruses for Studying Pathogenic and Pandemic Viruses$288,515
R43 · FY2025 · AI · contact PI
Specificity Screening Drug Development Tool for Biotherapeutic Safety$917,454
SB1 · FY2024 · GM · contact PI
Development of Safe and Rapid Reporter Viruses for Studying Pathogenic and Pandemic Viruses$288,515
R43 · FY2024 · AI · contact PI
Identifying Regulators of Cellular Aging that can Prevent Alzheimer's Disease$88,978
R43 · FY2023 · AG · contact PI
Identifying Regulators of Cellular Aging that can Prevent Alzheimer's Disease$358,588
R43 · FY2022 · AG · contact PI
Next Generation Specificity Screening for Biotherapeutics using an Extracellular Proteome Array$204,008
R44 · FY2022 · GM · contact PI
Next Generation Specificity Screening for Biotherapeutics using an Extracellular Proteome Array$502,372
R44 · FY2021 · GM · contact PI
Next Generation Specificity Screening for Biotherapeutics using an Extracellular Proteome Array$934,299
R44 · FY2020 · GM · contact PI
Development of CB1 Monoclonal Antibodies for Treating NASH$339,478
R44 · FY2020 · DK · contact PI
Development of CB1 Monoclonal Antibodies for Treating NASH$697,083
R44 · FY2019 · DK · contact PI
High-throughput Identification of Membrane Protein MAbs$261,975
R44 · FY2019 · GM · contact PI
Identifying New Immunomodulatory Targets for Alzheimers and Other Neurodegenerative Diseases$203,803
R43 · FY2019 · AG · contact PI
High-throughput Identification of Membrane Protein MAbs$524,675
R44 · FY2018 · GM · contact PI
Development of CB1 Monoclonal Antibodies for Treating NASH$438,450
R44 · FY2018 · DK · contact PI
Identifying New Immunomodulatory Targets for Alzheimers and Other Neurodegenerative Diseases$210,918
R43 · FY2018 · AG · contact PI
High-throughput Identification of Membrane Protein MAbs$100,000
R44 · FY2018 · GM · contact PI
High-throughput Identification of Membrane Protein MAbs$686,432
R44 · FY2017 · GM · contact PI
High-throughput Identification of Membrane Protein MAbs$224,752
R43 · FY2015 · GM · contact PI
Engineering Stable, Soluble, and Trimeric HIV gp140 by Paired Cys Scanning$246,301
R43 · FY2013 · AI · contact PI
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses$1,601,718
N01 · FY2012 · AI · contact PI
Engineering Stable, Soluble, and Trimeric HIV gp140 by Paired Cys Scanning$300,000
R43 · FY2012 · AI · contact PI
Phage Display Isolation of Antibodies against Antigenically Conserved Membrane Pr$214,214
R43 · FY2012 · GM · contact PI
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses$1,823,674
N01 · FY2011 · AI · contact PI
High-throughput Epitope Mapping of Anti-Viral Antibodies$242,376
R43 · FY2011 · AI · contact PI
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses$1,742,333
N01 · FY2010 · AI · contact PI
Cell-free Detection of GPCR Signaling in a Nanoscale System$386,159
R44 · FY2010 · GM · contact PI
A Tool for Modeling the Structure-Activity of Chemokine Receptors and Other GPCRs$663,634
R44 · FY2009 · GM · contact PI
Identification and Development of Novel Influenza M2 Inhibitors$500,000
U01 · FY2009 · AI · contact PI
Cell-free Detection of GPCR Signaling in a Nanoscale System$374,376
R44 · FY2009 · GM · contact PI
Identification of Novel Influenza Inhibitors$273,933
R43 · FY2009 · AI · contact PI
A Tool for Modeling the Structure-Activity of Chemokine Receptors and Other GPCRs$171,804
R44 · FY2009 · GM · contact PI
A Tool for Modeling the Structure-Activity of Chemokine Receptors and Other GPCRs$631,935
R44 · FY2008 · GM · contact PI
Cell-free Detection of GPCR Signaling in a Nanoscale System$432,390
R44 · FY2008 · GM · contact PI
Identification of Novel Influenza Inhibitors$325,310
R43 · FY2008 · AI · contact PI
A Tool for Modeling the Structure-Activity of Chemokine Receptors and Other GPCRs$775,397
R44 · FY2007 · GM · contact PI
A cell-free system for assaying ion channel function$388,702
R44 · FY2007 · GM · contact PI
Ion Channel Assay for Identifying Influenza Therapeutics$845,142
R01 · FY2006 · AI · contact PI
A cell-free system for assaying ion channel function$377,551
R44 · FY2006 · GM · contact PI
Modeling the Structure-Activity of Chemokine Receptors$222,303
R43 · FY2006 · GM · contact PI
Detection of GPCR Function in Cell-free Nanoscale System$97,370
R43 · FY2006 · GM · contact PI
A cell-free system for assaying ion channel function$381,232
R44 · FY2005 · GM
Detection of GPCR Function in Cell-free Nanoscale System$191,894
R43 · FY2005 · GM
Biosensor Optimization for Membrane Protein Studies$183,906
R44 · FY2005 · RR
Cell-free Biosensor for the Detection of Pathogens$100,000
R43 · FY2005 · AI
Pseudotype Production Optimization$407,670
R44 · FY2004 · GM
Biosensor Optimization for Membrane Protein Studies$363,800
R44 · FY2004 · RR
Biosensor Optimization for Membrane Protein Studies$646,013
R44 · FY2003 · RR
Pseudotype Production Optimization$454,750
R44 · FY2003 · GM
A cell-free system for assaying ion channel function$199,200
R43 · FY2003 · GM
HIV Envelope Cell-arrays$101,115
R43 · FY2002 · GM
ViraCore Biosensor Optimization$94,374
R43 · FY2002 · RR
ViraCore Pseudotype Production Optimization$94,374
R43 · FY2002 · GM